VanEck Pharmaceutical ETF (PPH)
NasdaqGM: PPH
· Echtzeitkurs · USD
111.21
+0.35 (0.32%)
Zum Schluss: Aug 17, 2026, 2:21 PM
VanEck Pharmaceutical ETF (PPH) ETF Price, Holdings & Analysis
0.32% (1D)
| Geld | 109.61 |
| Marktkapitalisierung | n/a |
| Fondsvermögen | 925.6 Mio |
| NAV | 110.83 |
| Beta | 0.4 |
| EPS (ttm) | k.A. |
| PE Ratio (ttm) | 24.63 |
| Ausstehende Anteile | 11.55 Mio |
| Auflagedatum | Dec 20, 2011 |
| Brief | 110.12 |
| Volumen | 60,830 |
| Ø Vol. (20D) | 265,674 |
| Eröffnung | 110.69 |
| Vortagesschluss | 110.86 |
| Tagesspanne | 110.47 - 111.57 |
| 52-Wk Range | 85.91 - 114.57 |
| Positionen | k.A. |
| Kostenquote | 0.36% |
Über PPH
The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The index includes common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Anlageklasse Equity
Tickersymbol PPH
Auflagedatum Dec 20, 2011
Anbieter Vaneck
Website Fonds-Homepage
Börse NasdaqGM
Top 10 Positionen 72.44% insgesamt
| Name | Symbol | Gewicht |
|---|---|---|
| Eli Lilly And Co | LLY | 19.12% |
| Novartis Ag Adr | NVS | 10.54% |
| Merck & Co Inc | MRK | 9.76% |
| Novo Nordisk As Adr | NVO | 5.67% |
| Bristol-myers Squibb... | BMY | 4.94% |
| Mckesson Corp | MCK | 4.63% |
| Abbvie Inc | ABBV | 4.59% |
| Pfizer Inc | PFE | 4.58% |
| Gsk PLC Adr | GSK | 4.31% |
| Johnson & Johnson | JNJ | 4.30% |
Dividenden Dividendenrendite 1.95%
| Ex-Dividende | Betrag | Zahldatum |
|---|---|---|
| Jul 1, 2026 | $0.6250 | k.A. |
| Apr 1, 2026 | $0.8440 | k.A. |
| Dec 29, 2025 | $0.3110 | k.A. |
| Oct 1, 2025 | $0.3930 | k.A. |
| Jul 1, 2025 | $0.6070 | k.A. |
Seite 1 von 2